Injectable Collagen Bone Graft
Bone defect / gap filling
Injectable collagen-based bone graft options from the Graftend and Goalie product families.
- Product type
- Injectable bone graft
- Application
- Bone defect / gap filling
- Material / Platform
- Collagen-based bone graft materials; approved product labeling should be consulted for model-specific composition and handling.
- Regulatory
- Graftend TFDA No. 007887 / Goalie TFDA No. 008321
Product Overview
This product family groups the injectable configurations of Socko Medical's collagen-based bone graft portfolio. Graftend and Goalie are supplied in distinct approved fill volumes and are designed for syringe-based delivery into suitable bone defects or gaps according to each product's approved Instructions for Use.
Design & product features
Injectable presentation
Graftend and Goalie product options
Sterile single-use configurations
Syringe-based delivery workflow
Models & Specifications
Available configurations within this product family. Refer to the current approved IFU and labeling for final model selection.
| Configuration | Details |
|---|---|
| 01 | Graftend Injectable: 3 mL |
| 02 | Goalie Injectable: 1.5 mL |
| 03 | Model-specific preparation and handling requirements follow the approved IFU |
Sterile, single use; refer to the applicable approved IFU and labeling for each product.
Indications Overview
The points below summarize the approved product family. Final patient selection and surgical use must follow the applicable approved Instructions for Use.
- Filling suitable bone defects or gaps as described in the approved IFU
- Injectable handling for sites where syringe-based delivery is clinically appropriate
- Use as a graft material rather than a structural load-bearing implant
Product Visualization